These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 10065805)

  • 21. Follicular and estradiol parameters that improve success with natural cycle in vitro fertilization.
    DiMattina M; Gordon JD; Botes A; Celia G; Payson M; Graves-Herring J
    J Reprod Med; 2014; 59(5-6):267-73. PubMed ID: 24937968
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Percentile curves of serum estradiol levels during controlled ovarian stimulation in 905 cycles stimulated with recombinant FSH show that high estradiol is not detrimental to IVF outcome.
    Papageorgiou T; Guibert J; Goffinet F; Patrat C; Fulla Y; Janssens Y; Zorn JR
    Hum Reprod; 2002 Nov; 17(11):2846-50. PubMed ID: 12407037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High estradiol levels and high oocyte yield are not detrimental to in vitro fertilization outcome.
    Sharara FI; McClamrock HD
    Fertil Steril; 1999 Sep; 72(3):401-5. PubMed ID: 10519607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum follicle-stimulating hormone inhibition is a marker for preovulatory oocytes in in-vitro fertilization and embryo transfer.
    Kreiner D; Itskovitz J; Droesch K; Navot D; Liu HC; Rosenwaks Z
    Hum Reprod; 1989 May; 4(4):381-3. PubMed ID: 2501334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing uterine receptivity by decreasing estradiol levels during the preimplantation period in high responders with the use of a follicle-stimulating hormone step-down regimen.
    Simón C; Garcia Velasco JJ; Valbuena D; Peinado JA; Moreno C; Remohí J; Pellicer A
    Fertil Steril; 1998 Aug; 70(2):234-9. PubMed ID: 9696213
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Luteal phase estradiol versus luteal phase estradiol and antagonist protocol for controlled ovarian stimulation before in vitro fertilization in poor responders.
    Elassar A; Mann JS; Engmann L; Nulsen J; Benadiva C
    Fertil Steril; 2011 Jan; 95(1):324-6. PubMed ID: 20797708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization.
    Droesch K; Muasher SJ; Brzyski RG; Jones GS; Simonetti S; Liu HC; Rosenwaks Z
    Fertil Steril; 1989 Feb; 51(2):292-7. PubMed ID: 2492234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of peak and mid-luteal estradiol levels on in vitro fertilization outcome.
    Moraloğlu Ö; Tonguc EA; Özel M; Özakşit G; Var T; Sarikaya E
    Arch Gynecol Obstet; 2012 Mar; 285(3):857-62. PubMed ID: 21938500
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A low-dose stimulation protocol using highly purified follicle-stimulating hormone can lead to high pregnancy rates in in vitro fertilization patients with polycystic ovaries who are at risk of a high ovarian response to gonadotropins.
    Marci R; Senn A; Dessole S; Chanson A; Loumaye E; De Grandi P; Germond M
    Fertil Steril; 2001 Jun; 75(6):1131-5. PubMed ID: 11384638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome.
    Loumaye E; Engrand P; Howles CM; O'Dea L
    Fertil Steril; 1997 May; 67(5):889-99. PubMed ID: 9130895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparison of GnRH antagonist fixed protocol and GnRH agonists long protocol in infertile patients with normal ovarian reserve function in their first in vitro fertilization-embryo transfer cycle].
    Yang S; Chen XN; Qiao J; Liu P; Li R; Chen GA; Ma CH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Apr; 47(4):245-9. PubMed ID: 22781108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IVF conversion to IUI in poor responders: an observational study.
    Freour T; Dubourdieu S; Mirallie S; Langlois ML; Jean M; Barrière P
    Arch Gynecol Obstet; 2010 Oct; 282(4):445-9. PubMed ID: 20499076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic importance of the number of oocytes retrieved and estradiol levels in poor and normal responders in in vitro fertilization (IVF) treatment.
    Dor J; Seidman DS; Ben-Shlomo I; Levran D; Karasik A; Mashiach S
    J Assist Reprod Genet; 1992 Jun; 9(3):228-32. PubMed ID: 1525451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Limited success using the "flare" protocol in poor responders in cycles with low basal follicle-stimulating hormone levels during in vitro fertilization.
    Karande V; Morris R; Rinehart J; Miller C; Rao R; Gleicher N
    Fertil Steril; 1997 May; 67(5):900-3. PubMed ID: 9130896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melatonin concentration in follicular fluid is correlated with antral follicle count (AFC) and in vitro fertilization (IVF) outcomes in women undergoing assisted reproductive technology (ART) procedures.
    Zheng M; Tong J; Li WP; Chen ZJ; Zhang C
    Gynecol Endocrinol; 2018 May; 34(5):446-450. PubMed ID: 29185361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Follicular atresia associated with concurrent initiation of gonadotropin-releasing hormone agonist and follicle-stimulating hormone for oocyte recruitment.
    Brzyski RG; Muasher SJ; Droesch K; Simonetti S; Jones GS; Rosenwaks Z
    Fertil Steril; 1988 Dec; 50(6):917-21. PubMed ID: 3144467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The significance of elevated early follicular-phase follicle stimulating hormone (FSH) levels: observations in unstimulated in vitro fertilization cycles.
    Lindheim SR; Sauer MV; Francis MM; Macaso TM; Lobo RA; Paulson RJ
    J Assist Reprod Genet; 1996 Jan; 13(1):49-52. PubMed ID: 8825167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age.
    Toner JP; Philput CB; Jones GS; Muasher SJ
    Fertil Steril; 1991 Apr; 55(4):784-91. PubMed ID: 1901282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant leuprolide in normal, abnormal, and poor responders to controlled ovarian hyperstimulation for in vitro fertilization/gamete intrafallopian transfer.
    Sathanandan M; Warnes GM; Kirby CA; Petrucco OM; Matthews CD
    Fertil Steril; 1989 Jun; 51(6):998-1006. PubMed ID: 2498135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.